Kennedy Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Kennedy Capital Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-43,399	Closed	-$2.24M	–	654
2022 Q3	$2.24M	Sell	43,399 -625	-1%	-$25.8K	0.07%	398
2022 Q2	$1.09M	Sell	44,024 -383	-0.9%	-$8.44K	0.03%	463
2022 Q1	$1.11M	Sell	44,407 -24,073	-35%	-$677K	0.03%	488
2021 Q4	$2.49M	Sell	68,480 -8,224	-11%	-$289K	0.05%	429
2021 Q3	$1.31M	Buy	+76,704	New	+$1.2M	0.03%	501
2021 Q1	–	Sell	-24,562	Closed	-$1.52M	–	722
2020 Q4	$1.52M	Sell	24,562 -241	-1%	-$13.8K	0.03%	526
2020 Q3	$1.36M	Sell	24,803 -194	-0.8%	-$10.4K	0.04%	523
2020 Q2	$1.44M	Buy	24,997 +27	+0.1%	+$1.47K	0.04%	542
2020 Q1	$1M	Buy	+24,970	New	+$1.06M	0.04%	562

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Kennedy Capital Management's CCXI Position: Q4 2022 in Review

Kennedy Capital Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 43,399 shares — an estimated $2.24M sold.

Kennedy Capital Management first reported a position in CCXI in Q1 2020 and held it in 9 quarters. The position peaked at $2.49M in Q4 2021. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Kennedy Capital Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Kennedy Capital Management sold 43,399 ChemoCentryx, Inc. shares in Q4 2022, an estimated $2.24M.
Kennedy Capital Management first reported a position in ChemoCentryx, Inc. in Q1 2020 and held it in 9 quarters.
Kennedy Capital Management's ChemoCentryx, Inc. position peaked at $2.49M in Q4 2021.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Kennedy Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.